Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator

Semin Thromb Hemost. 1987 Apr;13(2):171-7. doi: 10.1055/s-2007-1003489.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Angiography
  • Clinical Trials as Topic
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrinogen / metabolism
  • Heparin / therapeutic use
  • Humans
  • Pulmonary Embolism / drug therapy*
  • Pulmonary Wedge Pressure
  • Recombinant Proteins / therapeutic use*
  • Tissue Plasminogen Activator / pharmacology
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrin Fibrinogen Degradation Products
  • Recombinant Proteins
  • Fibrinogen
  • Heparin
  • Tissue Plasminogen Activator